Medicare beneficiaries who rely on Part D prescription drug coverage will face a higher out-of-pocket threshold before their plans begin paying for medications in 2027. The Centers for Medicare and Medicaid Services (CMS) set the standard Part D deductible cap at $700 for the 2027 plan year, an $85 increase from the $615 maximum allowed in 2026. The jump lands during a period when drug costs and plan design choices are already reshaping how retirees pick coverage each fall.
How the $700 deductible cap changes Part D math for 2027
The deductible increase traces directly to CMS policy decisions finalized earlier this year. On April 6, 2026, the agency published its annual rate announcement, which locked in benefit parameters for every standalone Part D and Medicare Advantage prescription drug plan entering the market next year. The $700 figure also appears in the Retiree Drug Subsidy program’s cost threshold for plan years ending in 2027, tying employer-sponsored retiree plans to the same benchmark.
No Medicare drug plan may set a deductible above the annual cap, but plans can choose to charge less or waive the deductible entirely. That flexibility creates a competitive gap. Beneficiaries without Low-Income Subsidy assistance pay the full deductible out of pocket before reaching the initial coverage phase, where cost-sharing kicks in. An $85 increase means those enrollees could spend noticeably more on generics and brand-name drugs in the early months of a plan year before any coverage applies, especially if they take multiple maintenance medications.
Plans that hold deductibles well below $700 stand to attract enrollees who compare costs during the annual open enrollment period. Non-subsidized beneficiaries, who shoulder the entire deductible themselves, have the strongest financial incentive to shop for lower-deductible options. If enough plans cluster near the new ceiling, the gap between a $700-deductible plan and one charging $300 or $400 becomes a clear selling point during fall enrollment season, particularly for people who expect to fill prescriptions right away in January.
The higher deductible also interacts with other parts of the Part D benefit. Because beneficiaries must first satisfy the deductible before most plan cost-sharing applies, a larger threshold can delay when enrollees begin sharing costs with their plan and when they progress through the initial coverage phase. For people with modest drug needs, that may mean they never move beyond the deductible at all, effectively paying the full cost of their prescriptions up to the $700 limit.
CMS rate parameters and the Retiree Drug Subsidy link
CMS framed the 2027 payment policies as steps to support accountability and sustainability across Medicare Advantage and Part D. The deductible cap is one of several benefit parameters that adjust annually based on per-capita spending trends in the program. Because the cap rises with aggregate drug spending, faster growth in prescription costs pushes the threshold higher for everyone, even when individual beneficiaries’ medication lists do not change.
The Retiree Drug Subsidy (RDS) program uses the same $700 cost threshold to determine the spending band in which employers and unions can claim federal subsidies for retiree drug coverage. In its announcement of cost threshold amounts for plan years ending in 2027, CMS aligned the RDS floor with the Part D deductible cap, reinforcing a single benchmark across individual and group retiree markets. Employers that sponsor qualifying plans watch this number closely because it sets the point at which subsidy-eligible spending begins.
A higher threshold means retiree plans must cover more of their participants’ drug costs before the federal subsidy calculation starts. That shift can influence how employers structure benefits, including decisions about whether to mirror the standard Part D design, set lower internal deductibles, or adjust premium contributions. Some sponsors may choose to absorb more of the upfront spending to keep retiree out-of-pocket costs stable, while others could pass more of the early-year expense to retirees through higher deductibles or coinsurance.
The current 2026 rule, as stated on the official Medicare consumer site, caps the deductible at $615. That baseline makes the 2027 increase roughly 14 percent year over year, a pace that outstrips typical consumer inflation and underscores how quickly prescription spending is rising inside the Part D program. For beneficiaries on fixed incomes, even an $85 change can alter monthly budgeting, particularly when combined with any premium adjustments or shifts in plan formularies.
What beneficiaries and plan sponsors should watch next
For Medicare enrollees, the new deductible cap raises the stakes for plan comparison during the upcoming open enrollment period. Beneficiaries will need to look beyond premiums and check how each plan handles deductibles, which drugs are subject to the deductible, and what they will pay at the pharmacy counter before coverage begins. Tools that estimate total annual costs, rather than just monthly premiums, become more important as the deductible climbs.
Plan sponsors and employers, meanwhile, must balance the higher deductible benchmark against their own cost and competitiveness pressures. Insurers that keep deductibles below the $700 ceiling may gain an edge with cost-sensitive seniors, but they will have to offset that generosity elsewhere in the benefit or through premiums. Employers offering retiree coverage face similar trade-offs as they evaluate whether to maintain current benefit levels or redesign plans around the updated RDS thresholds.
With the 2027 parameters now finalized, both beneficiaries and plan designers have a clear signal: rising drug spending is feeding directly into higher front-end costs in Part D. How plans respond to that signal-and how retirees adapt their coverage choices-will determine who ultimately bears the brunt of the new $700 deductible cap.
Free for readers: The free Retirement Shield newsletter sends plain-English help keeping more of your money in retirement — the scams to dodge, the benefits you’re owed, and what’s changing with Social Security and Medicare, a couple times a week. Get the free newsletter.
